Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.

Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC.

J Clin Psychiatry. 2004 Oct;65(10):1377-88.

PMID:
15491242
2.

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003.

Lehman AF, Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, Goldberg R, Green-Paden LD, Tenhula WN, Boerescu D, Tek C, Sandson N, Steinwachs DM.

Schizophr Bull. 2004;30(2):193-217.

3.

Dose response and dose equivalence of antipsychotics.

Davis JM, Chen N.

J Clin Psychopharmacol. 2004 Apr;24(2):192-208. Review.

PMID:
15206667
5.
6.

Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital.

Advokat C, Dixon D, Schneider J, Comaty JE Jr.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):487-95.

PMID:
15093956
7.

Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits.

Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ.

Am J Psychiatry. 2004 Apr;161(4):700-6.

PMID:
15056517
8.

Practice guideline for the treatment of patients with schizophrenia, second edition.

Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J; American Psychiatric Association; Steering Committee on Practice Guidelines.

Am J Psychiatry. 2004 Feb;161(2 Suppl):1-56. Review. No abstract available.

PMID:
15000267
9.

The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a medicaid population.

Gibson PJ, Damler R, Jackson EA, Wilder T, Ramsey JL.

Value Health. 2004 Jan-Feb;7(1):22-35.

PMID:
14720128
10.

Polypharmacy in patients with schizophrenia.

McCue RE, Waheed R, Urcuyo L.

J Clin Psychiatry. 2003 Sep;64(9):984-9.

PMID:
14628972
11.

Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.

Loosbrock DL, Zhao Z, Johnstone BM, Morris LS.

J Ment Health Policy Econ. 2003 Jun;6(2):67-75.

PMID:
14578539
12.

Multiple antipsychotic medication prescribing patterns.

Schumacher JE, Makela EH, Griffin HR.

Ann Pharmacother. 2003 Jul-Aug;37(7-8):951-5.

PMID:
12841799
13.
14.

Antipsychotic medication coprescribing in a large state hospital system.

Jaffe AB, Levine J.

Pharmacoepidemiol Drug Saf. 2003 Jan-Feb;12(1):41-8.

PMID:
12616846
15.

Combination antipsychotic therapy in clinical practice.

Tapp A, Wood AE, Secrest L, Erdmann J, Cubberley L, Kilzieh N.

Psychiatr Serv. 2003 Jan;54(1):55-9.

PMID:
12509667
16.

Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations.

Freudenreich O, Goff DC.

Acta Psychiatr Scand. 2002 Nov;106(5):323-30. Review.

PMID:
12366465
17.
19.
20.

Combination antipsychotics: pros, cons, and questions.

Miller AL, Craig CS.

Schizophr Bull. 2002;28(1):105-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk